President Trump yesterday issued an executive order establishing a commission to study the scope and effectiveness of the federal response to drug addiction and the opioid crisis, and make recommendations to him for improving the response. The executive order calls for the commission to submit interim recommendations within 90 days and final recommendations by Oct. 1, unless the chair requests an extension. The commission will be administered by the Office of National Drug Control Policy, and its members and chair appointed by President Trump.

Related News Articles

Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
The Food and Drug Administration yesterday announced changes to the prescribing information included in outpatient opioid pain medication labels.
Headline
The Agency for Healthcare Research and Quality is accepting comments through April 25 on a draft report on treatment for acute pain.
Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…